Skip to main content
Haisco Pharmaceutical Group Co.,Ltd logo

Haisco Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 002653 ISIN · CNE100001BC7 LEI · 300300GRLH34A8GPJ639 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,439 across all filing types
Latest filing 2024-05-15 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002653

About Haisco Pharmaceutical Group Co.,Ltd

https://www.haisco.com

Haisco Pharmaceutical Group Co.,Ltd. focuses on the research, development, production, and commercialization of innovative drugs and high-end generic pharmaceuticals. The company maintains a specialized portfolio across therapeutic areas including anesthesia, parenteral nutrition, anti-infection, cardiovascular health, and endocrine disorders. Key products include advanced anesthetic agents and specialized nutritional injections designed for clinical use. Haisco prioritizes technological innovation through a dedicated R&D infrastructure, targeting the development of small molecule chemical drugs and complex delivery systems. Its operations emphasize high-standard manufacturing processes and the integration of clinical research to address complex medical requirements. The company aims to provide therapeutic solutions that enhance patient care through a commitment to scientific excellence and product quality.

Recent filings

Filing Released Lang Actions
北京市中伦（深圳）律师事务所关于海思科医药集团股份有限公司2023年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2023 Annual General Meeting (AGM) of the company. It discusses the procedures for convening and holding the AGM, the qualifications of the convener and attendees, the voting procedures, and the voting results for various proposals including the 2023 financial report, annual report, board work report, and other governance matters. The document does not contain the actual financial reports or detailed financial data but rather certifies the legality and validity of the AGM process and voting outcomes. The document length is 4330 characters, which is relatively short and consistent with a legal opinion or meeting procedural document rather than a full report. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of the AGM.
2024-05-15 Chinese
关于获得创新药HSK39004吸入混悬液IND申请受理通知书的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a pharmaceutical company about receiving an acceptance notice from the National Medical Products Administration for an IND (Investigational New Drug) application for a new drug. It includes details about the drug, regulatory acceptance, and risk warnings. The document is short (844 characters) and serves as an official announcement of a regulatory event rather than a detailed report or financial filing. It does not contain financial data, management changes, voting results, or detailed financial statements. Therefore, it fits best into the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-05-15 Chinese
关于控股股东部分股份解除质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the release of pledged shares by a controlling shareholder of the company. It details the number of shares released from pledge, the shareholder's name, and related shareholding percentages. There is no financial report, earnings data, or management discussion. The content is about a change in share pledge status, which relates to shareholding and capital structure but is not a financing update or capital raising event. It is a regulatory announcement about share pledge release, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories like Major Shareholding Notification (MRQ) because it concerns pledge release, not share ownership threshold crossing, nor is it a share issue or capital change (SHA). The document length is short and it is an announcement, not a report. Therefore, the best classification is Regulatory Filings (RNS).
2024-05-06 Chinese
关于举行2023年度网上业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about holding the 2023 annual performance explanation meeting (业绩说明会) online. It references that the 2023 annual report has already been published on April 20, 2024, and invites investors to participate in the upcoming performance explanation meeting on May 10, 2024. The document does not contain the actual annual report or detailed financial data but serves as a notice for the event and a call for investor questions. The document length is short (770 characters), and it is clearly an announcement rather than the report itself. Therefore, it fits the category of Investor Presentation (IP) since it is about a detailed presentation for investors focusing on financials and company performance, or possibly AGM Information (AGM-R) if it were an AGM. However, since this is specifically a performance explanation meeting (业绩说明会), which is typically an investor presentation, the best fit is Investor Presentation (IP).
2024-05-06 Chinese
第五届董事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 14th meeting of the 5th Board of Directors of the company. It includes details about board decisions such as amendments to the company bylaws, change of legal representative, establishment of a subsidiary, and impairment provisions. The document explicitly states voting results and references related announcements published elsewhere. It does not contain financial statements or detailed financial data but rather reports on board decisions and approvals. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management and related board resolutions.
2024-04-30 Chinese
关于修订《公司章程》的公告
Governance Information Classification · 95% confidence The document is a detailed announcement about the revision of the company's Articles of Association (公司章程). It includes specific changes to the company's governance rules, share capital, shareholder rights, board responsibilities, and other corporate governance matters. The document is issued by the company's board and is intended for shareholders, requiring approval at the upcoming annual general meeting. There is no financial data, earnings information, or audit content. It is not a report itself but an official announcement of governance changes. This fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2024-04-30 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.